RAC2-Related Combined Immunodeficiency: A Patient Guide

How Strong Is the Evidence?
RAC2-related combined immunodeficiency is exceptionally rare. Many recommendations are extrapolated from broader primary immunodeficiency guidelines or individual case reports. Care must be individualized by an expert center. The bracketed citation codes in this guide (such as ^[1]) refer to specific medical literature identifiers that your doctor can look up.

RAC2-related combined immunodeficiency is an exceptionally rare genetic condition that affects the very foundation of how your immune system moves and reacts. At its core, the condition is caused by a mutation in the RAC2 gene, which acts as a “molecular switch” within your white blood cells ^[1]. When this switch is malfunctioning, your immune cells cannot properly reshape their internal skeletons to crawl toward an infection or signal for help when they encounter a virus. This fundamental breakdown in cellular communication and movement is why the condition can affect so many different parts of the body at once, from the skin and lungs to the blood itself ^[2].

Because the RAC2 protein is used by several types of white blood cells, the symptoms can vary widely depending on exactly how the genetic “switch” is broken. For some, the primary challenge is a shortage of T and B cells, which are the specialized cells of the immune system. For others, the main issue lies with neutrophils, the cells that act as the body’s first responders to bacterial infections. This variation means that while one person may experience severe illness starting at birth, another might not be diagnosed until later in childhood or even adulthood when persistent respiratory or viral issues become more apparent ^[1][3].

Living with this condition requires a proactive, multidisciplinary approach focused on protecting your long-term health. Depending on the individual immune phenotype, infection history, organ findings, and treatments already received, management may involve a combination of preventing infections through antibody support, maintaining clear airways to prevent lung scarring, and staying vigilant against persistent viruses like HPV and EBV. Consistent long-term monitoring is essential to catch and treat any cellular changes early ^[4][5].

While the journey with a rare diagnosis can feel uncertain, the medical community’s understanding of RAC2 is growing rapidly. For some patients, the goal is successful long-term medical management, while for others, a hematopoietic cell transplant (HSCT) may replace defective hematopoietic immune cells, though it is not a guaranteed cure and does not reverse established organ damage. Regardless of the path forward, the focus remains on building a specialized care team that can tailor treatments to your specific genetic blueprint, ensuring that you or your child can lead the healthiest and most active life possible ^[6][7].